3 New Strong Buy Ratings from Top-Rated Analysts: 03/24/2026
Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
- SanDisk (NASDAQ: SNDK) enjoys solid demand
- Lockheed Martin Corp (NYSE: LMT) is soaring amid global tensions
- Jazz Pharmaceuticals (NASDAQ: JAZZ) has over 50% potential upside in the coming year
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The ONLY AI opportunity you should be looking at
This is the ONLY AI wealth-building opportunity you should be watching right now.
No. It's not about Nvidia, Tesla, or Meta...
It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.
This new opportunity will change the market and make investors a lot of money.
That's why it has received a $500 billion commitment from President Trump himself...
Learn more about this little-known company here >>>
1. SanDisk (NASDAQ: SNDK)
SanDisk is a NAND flash storage powerhouse behind SSDs, embedded tech, and removable storage. After a jaw-dropping 1,200% run fueled by AI hype, it’s now at the center of a high-stakes question: real demand—or a bubble about to burst?
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $709.71 — get current quote
Max 1-year forecast: $875.00
Why we're watching:
- Analyst support: SNDK enjoys 9 Strong Buy ratings, 3 Buy ratings, and 4 Hold ratings. See the ratings
- Citigroup researcher Asiya Merchant (a top 1% rated analyst) recently maintained her Strong Buy rating with an $875.00 price target; Cantor Fitzgerald researcher C.J. Muse (a top 3% rated analyst) recently maintained his Strong Buy rating with an $800.00 price target, demonstrating continued confidence in the company's positioning.
- Revenue is forecast to explode +74.35% to $15.6B in the coming year, with two-year growth projections of +198.22%, driven by surging AI infrastructure demand for high-performance storage solutions.
- Industry ranking context: SNDK is currently the #1 highest-rated stock in the Computer Hardware industry — but note that this market niche has an Industry Rating of D.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, and SNDK's momentum continues to attract top-tier analyst support despite concerns about valuation.
- Component Grades: The company demonstrates exceptional growth credentials with an A rating in Growth and Sentiment, complemented by B ratings in Momentum and Financials, though Value and Safety receive C ratings reflecting elevated valuation concerns. See all 7 Zen Component Grades here
2. Lockheed Martin Corp (NYSE: LMT)
Lockheed Martin is a global defense giant powering advanced aircraft and missile systems. With delayed F-16 deliveries to Taiwan now back on track and new defense initiatives underway, it remains a cornerstone player—despite recent market swings.
Zen Rating: B (Buy) — see full analysis
Recent Price: $627.43 — get current quote
Max 1-year forecast: $740.00
Why we're watching:
- Analyst support: We’ll be real with you: the coverage is mixed, with 12 total analysts providing 2 Strong Buy ratings, 1 Buy rating, 8 Hold ratings, and 1 Strong Sell rating. See the ratings
- Looking at the bullish parties, Susquehanna researcher Charles Minervino (a top 3% rated analyst) recently maintained his Strong Buy rating with a $740.00 price target (+17.94% upside), the highest among covering analysts.
- Truist Securities' Michael Ciarmoli (a top 1% rated analyst) recently upgraded the stock to Strong Buy with a $605.00 price target, signaling improving conviction despite near-term headwinds.
- The company demonstrates exceptional financial strength with a 125.85% return on equity and earnings forecast to grow +40.01% to $30.19 per share, driven by strong defense spending and growing international demand.
- Industry ranking context: LMT is currently the 10th highest-rated stock out of 76 in the Defense industry, which has an Industry Rating of C.
- Zen Rating highlights: LMT is B (Buy) rated according to our Zen Ratings. Its defensive qualities and strong Component Grades (see next bullet) make it attractive for risk-conscious investors seeking exposure to defense spending trends.
- Component Grades: Lockheed Martin shows exceptional safety with an A rating in Safety, complemented by strong B ratings in Value, Momentum, and Financials, though Growth and Sentiment receive C ratings reflecting mature market dynamics. See all 7 Zen Component Grades here
3. Jazz Pharmaceuticals (NASDAQ: JAZZ)
Jazz Pharmaceuticals is a global biopharma player targeting high-need diseases. With promising oncology data heading into AACR 2026 and strong analyst backing, the stock sits near its lows—setting up a potential upside surprise.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $180.62 — get current quote
Max 1-year forecast: $275.00
Why we're watching:
- Analyst support: JAZZ enjoys 7 Strong Buy ratings, 3 Buy ratings, and 1 Hold rating, resulting in a Strong Buy consensus. See the ratings here
- Bank of America researcher Jason Gerberry (a top 15% rated analyst) recently maintained his Strong Buy rating with a $275.00 price target (+52.25% upside), the highest on the Street.
- Wells Fargo researcher Mohit Bansal (a top 15% rated analyst) recently maintained his Strong Buy rating with a $250.00 price target following recent conference presentations.
- The company demonstrates strong profitability with a 17% profit margin and robust return on equity of 44.06%, while revenue is expected to grow +6.17% to $4.5B with improving earnings trajectory.
- Industry ranking context: JAZZ is currently the 4th highest-rated stock in the Biotech industry, which has an Industry Rating of F, making it a standout performer in a challenging sector.
- Zen Rating highlights: As an A-rated stock, JAZZ ranks in the top 5% of the 4600+ stocks we track, with outstanding fundamentals: It boasts Component Grades of A for Value and Growth, complemented by B ratings in Financials and AI. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.